Treatment of SARS-CoV-2 infection with a ribonucleoside analogue, MK-4482/EIDD-2801 or Molnupiravir, suppresses coronavirus transmission within 24 hours, researchers report.
Molnupiravir has broad-spectrum activity against respiratory RNA viruses.
New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours
Comentarios